Clozapine prescribing during follow-up of a first-episode psychosis cohort

Introduction Of those with schizophrenia, one third develop treatment-resistant illness. Nearly 60% of these benefit from clozapine- the only antipsychotic medication licensed in this group. Objectives As treatment-resistant illness developed in the follow-up of a first-episode psychosis (FEP) c...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	R. Rowntree, F. Fanning, D. Keating, S. Murray, A. Szigeti, R. Doyle, S. Mcwilliams, M. Clarke
Format:	Artigo
Sprog:	Inglês
Udgivet:	Cambridge University Press 2021-04-01
Serier:	European Psychiatry
Fag:	first-episode psychosis psychosis treatment-resistant schizophrenia clozapine
Online adgang:	https://www.cambridge.org/core/product/identifier/S0924933821021246/type/journal_article
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!